Jun Li

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 243 citations

Hepatology, Medicine, Pathology +6

Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks

Jun Li, Chao Guo, Xiuli Lu et al. · European Journal of Pharmacology · 2019 · 49 citations

Biological Mechanisms, Molecular Networks, Chemoprevention Strategy +11

Burden of colorectal cancer in China, 1990−2017: Findings from the Global Burden of Disease Study 2017

Jie Yin, Zhigang Bai, Jun Zhang et al. · Chinese Journal of Cancer Research · 2019 · 47 citations · Full text

Trends in modifiable lifestyle-related risk factors following diagnosis in breast cancer survivors

Guixiang Zhao, Chaoyang Li, Catherine A. Okoro et al. · Journal of Cancer Survivorship · 2013 · 46 citations · Full text

Preventive Medicine, Cancer Risk, Health Policy +11

Intimal Hyperplasia and Expression of Transforming Growth Factor-β1 in Saphenous Veins and Internal Mammary Arteries Before Coronary Artery Surgery

Reinhard Friedl, Jun Li, B. Schumacher et al. · The Annals of Thoracic Surgery · 2004 · 41 citations · Full text

Saphenous Veins, Angiogenesis, Developmental Biology +11